For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Berlin D-12203

0 studies enrolling now · 60 studies all time

What they study most

Alzheimer's Disease, Autoimmune Disease, Axial Spondyloarthritis, Benign Prostatic Hyperplasia, Carcinoma, Hepatocellular, Carcinoma, Non-Small-Cell Lung, Cardiovascular Disease, Cardiovascular Diseases, Chronic Low Back Pain, Chronic Migraine, Connective Tissue Disease, Coronary Artery Disease

Studies at this site

• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer — Running, not enrolling
• A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein — Completed
• Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
• A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer — Completed
• A Study of LY2157299 in Participants With Hepatocellular Carcinoma — Completed
• A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) — Completed
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) — Completed
• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis — Completed
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis — Completed
• A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis — Completed
• A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) — Stopped early
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) — Completed
• Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease — Stopped early
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis — Completed
• A Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes — Completed
• Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes — Completed
• A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study LY2228820 for Recurrent Ovarian Cancer — Completed
• A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread — Completed
• A Study in Men With Benign Prostatic Hyperplasia — Stopped early
• A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) — Completed
• A Study of Enzastaurin in Participants With Follicular Lymphoma — Completed
• PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin — Completed
• A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma — Stopped early
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Study in Participants With Rheumatoid Arthritis — Stopped early
• A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor — Completed
• A Study for Participants With Pancreatic Cancer — Completed
• A Study in Participants With Type 2 Diabetes Mellitus — Completed
• A Study in Participants With Type 1 Diabetes Mellitus — Completed
• A Study of LY2484595 in Patients With High LDL-C or Low HDL-C — Completed
• A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy — Completed
• Second Study of the Effect of Teriparatide on Hip Fracture Healing — Completed
• Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo — Completed
• Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) — Withdrawn before enrolling
• A Study of Duloxetine in Elderly Generalized Anxiety Disorder — Completed
• Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs — Completed
• A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms — Completed
• Effect of LY2062430 on the Progression of Alzheimer's Disease — Completed
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock — Completed
• Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) — Stopped early
• Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder — Completed
• A Study in Patients With Type 2 Diabetes — Withdrawn before enrolling